Novo Holdings A/S’s Mirum Pharmaceuticals MIRM Stock Holding History

Novo Holdings A/S’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$122M	Buy	1,325,000 +60,972	+5%	+$5.74M	9.92%	4
2025 Q4	$99.8M	Hold	1,264,028	–	–	7.75%	4
2025 Q3	$92.7M	Sell	1,264,028 -236,027	-16%	-$15M	5.97%	4
2025 Q2	$76.3M	Buy	1,500,055 +55	+0%	+$2.45K	5.39%	5
2025 Q1	$67.6M	Hold	1,500,000	–	–	5.14%	6
2024 Q4	$62M	Hold	1,500,000	–	–	3.76%	8
2024 Q3	$58.5M	Hold	1,500,000	–	–	2.91%	9
2024 Q2	$51.3M	Hold	1,500,000	–	–	2.76%	10
2024 Q1	$37.7M	Hold	1,500,000	–	–	2.6%	12
2023 Q4	$44.3M	Hold	1,500,000	–	–	2.73%	11
2023 Q3	$47.4M	Sell	1,500,000 -184,193	-11%	-$5.04M	3.5%	9
2023 Q2	$43.6M	Hold	1,684,193	–	–	3.37%	9
2023 Q1	$40.5M	Hold	1,684,193	–	–	2.67%	14
2022 Q4	$32.8M	Hold	1,684,193	–	–	2.05%	18
2022 Q3	$35.4M	Sell	1,684,193 -343,131	-17%	-$8.26M	1.69%	16
2022 Q2	$37.9M	Sell	2,027,324 -172,676	-8%	-$4.07M	1.87%	16
2022 Q1	$48.4M	Sell	2,200,000 -245,147	-10%	-$5M	2.56%	12
2021 Q4	$39M	Hold	2,445,147	–	–	1.85%	11
2021 Q3	$48.7M	Hold	2,445,147	–	–	2.52%	10
2021 Q2	$42.3M	Hold	2,445,147	–	–	1.88%	15
2021 Q1	$48.5M	Hold	2,445,147	–	–	2%	16
2020 Q4	$42.7M	Hold	2,445,147	–	–	1.83%	15
2020 Q3	$47.1M	Hold	2,445,147	–	–	2.34%	12
2020 Q2	$47.6M	Hold	2,445,147	–	–	3.07%	9
2020 Q1	$34.2M	Hold	2,445,147	–	–	2.28%	7
2019 Q4	$60M	Hold	2,445,147	–	–	3.86%	5
2019 Q3	$24.6M	Buy	+2,445,147	New	+$30M	4.21%	6

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Novo Holdings A/S's MIRM Position: Q1 2026 in Review

Novo Holdings A/S increased its Mirum Pharmaceuticals (MIRM) stake by 4.8% in Q1 2026, buying an estimated $5.74M and bringing the position to 1,325,000 shares worth $122M. The position accounts for 9.92% of the portfolio, ranked #4.

Novo Holdings A/S first reported a position in MIRM in Q3 2019 and has held it in 27 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

Novo Holdings A/S held 1,325,000 shares of Mirum Pharmaceuticals worth $122M as of Q1 2026.
Novo Holdings A/S bought 60,972 Mirum Pharmaceuticals shares in Q1 2026, an estimated $5.74M.
Mirum Pharmaceuticals made up 9.92% of Novo Holdings A/S's portfolio in Q1 2026, its #4 holding.
Novo Holdings A/S first reported a position in Mirum Pharmaceuticals in Q3 2019 and has held it in 27 quarters since.
311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Novo Holdings A/S's 13F filing for Q1 2026, filed 15 May 2026.